Stay updated with breaking news from T Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patients get the same benefit from these powerful therapies.
In an 11-year study, researchers at the National Institutes of Health have further characterized idiopathic CD4 lymphocytopenia (ICL), a rare immune deficiency that leaves people vulnerable to infectious diseases, autoimmune diseases and cancers.
Gut bacteria that break down a sugar called fucose could be dampening our immune response to the COVID-19 mRNA vaccine, according to a study led by researchers from the Okinawa Institute of Science and Technology.
The findings illustrate the important impact that the trillions of bacteria in our gut -- collectively called our 'gut microbiome' -- have on our immune health and add a missing piece to the puzzle of why vaccination varies in effectiveness from person to person
MyJournals.org - Science - 'IJMS, Vol. 24, Pages 7626: Mutated Flt3Lg Provides Reduced Flt3 Recycling Compared to Wild-Type Flt3Lg and Retains the Specificity of Flt3Lg-Based CAR T-Cell Targeting in AML Models' (International Journal of Molecular Sciences)